Form 4: Kathleen Sebelius Reports Acquisition of 6,889 Shares of Exact Sciences Corp.
SEC Form 4 Filing
Director Kathleen Sebelius reports acquiring 6,889 shares of Exact Sciences Corp. common stock on June 13, 2024, as part of the company's non-employee director compensation policy.
Summary
- Kathleen Sebelius, a director of Exact Sciences Corp., filed a Form 4 on June 17, 2024, reporting a transaction.
- On June 13, 2024, she acquired 6,889 shares of common stock.
- These shares were issued as restricted stock under the company's non-employee director compensation policy.
- Following the transaction, Sebelius directly owns 31,888 shares of Exact Sciences Corp.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. A director acquiring shares is generally a good sign, indicating confidence in the company's future. The acquisition is part of a pre-defined compensation policy, so it's not necessarily a surprise, but still a positive signal.
Positives
- The acquisition of shares by a director signals confidence in the company.
Management Comments
- These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.
Industry Context
Director stock ownership is a common practice in publicly traded companies to align the interests of directors with those of shareholders.
Stakeholder Impact
- The acquisition of shares by a director can positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of transaction: Kathleen Sebelius acquired 6,889 shares of Exact Sciences Corp. |
| 06/17/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.